2.3.2.5: glutaminyl-peptide cyclotransferase
This is an abbreviated version!
For detailed information about glutaminyl-peptide cyclotransferase, go to the full flat file.
Word Map on EC 2.3.2.5
-
2.3.2.5
-
pyroglutamate
-
alzheimer
-
cyclases
-
pyroglutamyl
-
papaya
-
pyroglutamate-modified
-
pglu-a
-
medicine
-
drug development
-
antivenomics
-
pharmacology
-
n-truncated
-
cd47-sirp
- 2.3.2.5
- pyroglutamate
- alzheimer
- cyclases
-
pyroglutamyl
- papaya
-
pyroglutamate-modified
-
pglu-a
- medicine
- drug development
-
antivenomics
- pharmacology
-
n-truncated
-
cd47-sirp
Reaction
Synonyms
AtQC, cyclotransferase, glutaminyl-transfer ribonucleate, DromeQC, gamma-glutamylamine cyclotransferase, GGACT, glutamine cyclotransferase, glutaminyl cyclase, glutaminyl-peptide cyclotransferase-like protein, glutaminyl-tRNA cyclotransferase, golgi resident enzyme, Golgi resident glutaminyl cyclase, Golgi-resident enzyme, Golgi-resident glutaminyl cyclase, gQC, h-isoQC, h-QC, hQC, isoDromeQC, isoGlutaminyl cyclase, isoQC, PgQC, QC, QCT, Qpct, Qpct1, QPCTL, secretory glutaminyl cyclase, sQC, StQC
ECTree
Advanced search results
Engineering
Engineering on EC 2.3.2.5 - glutaminyl-peptide cyclotransferase
Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
C113A/C136A
mutant of isoform DromeQC lacking a disulfide bond, without influence on the stability of the enzyme
C136A/C158A
mutant of isoform isoDromeQC lacking a disulfide bond, without influence on the stability of the enzyme
D248A
D305A
E201D
E201L
site-directed mutagenesis, the mutant is inactive, the side chain of L201 has oriented away from the D305 in the mutant structure
E201Q
E225G
site-directed mutagenesis, the mutant shows reduced enzymatic activity compared to wild-type
F146A
the ratio of turnover-number to KM-value for Gln-Gln at pH 8.0 is 1.43fold lower than wild-type ratio
F325A
F325N
the mutant shows a 815fold increase in Ki of PBD150 compared to the wild type enzyme
F325Y
the mutant shows a 381fold increase in Ki of PBD150 compared to the wild type enzyme
I303A
the mutation results in a 66.3fold increase in the Ki value of PBD150 compared to the wild type enzyme
I303F
the mutation results in a 6.2fold increase in the Ki value of PBD150 compared to the wild type enzyme
I303N
the mutation results in a 112fold increase in the Ki value of PBD150 compared to the wild type enzyme
I303V
the mutation results in a 1.9fold increase in the Ki value of PBD150 compared to the wild type enzyme
I73N/C369A
-
further improvement of enzyme secretion (expressed in Pichia pastoris)
K144A
K144M
the mutant shows a 335fold increase in Ki of PBD150 compared to the wild type enzyme
K144R
the mutant shows a 237fold increase in Ki of PBD150 compared to the wild type enzyme
N49A
-
mutant enzyme is not glycosylated, kinetic properties are indistinguishable from unmutated enzyme
Q304L
the ratio of turnover-number to KM-value for Gln-Gln at pH 8.0 is 1.7fold lower than wild-type ratio
R54W
the ratio of turnover-number to KM-value for Gln-Gln at pH 8.0 is 1.4fold lower than wild-type ratio
S160G
S323A
the mutation leads to a significant decrease (0.2fold) in the Ki value of PBD150 compared to the wild type enzyme
S323T
the mutation leads to a significant decrease (0.21fold) in the Ki value of PBD150 compared to the wild type enzyme
S323V
the mutation leads to a strong decrease (0.074fold) in the Ki value of PBD150 compared to the wild type enzyme
W207F
W207L
W207Q
the mutation alters substrate conversion significantly, while the binding constants of inhibitors such as the highly potent PBD150 are minimally affected
W329A
the ratio of turnover-number to KM-value for Gln-Gln at pH 8.0 is 297fold lower than wild-type ratio
W329F
the mutation leads to a significant decrease (0.56fold) in the Ki value of PBD150 compared to the wild type enzyme
W329Y
the mutation does not affect the Ki of PBD150 compared to the wild type enzyme
Y115E/Y117E
Y299A
the mutant shows a 122fold increase in Ki of PBD150 compared to the wild type enzyme
Y299F
the mutant shows a 220fold increase in Ki of PBD150 compared to the wild type enzyme
Q46E
the mutants pH optimum is shifted towards lower pH values, although the activity towards L-glutamine-2-naphtylamine is some 1000fold lower than the wild type
E45A
the mutation leads to a drop in the enzyme activity (1.12% activity compared to the wild type enzyme)
E45Q
the mutation increases the enzyme activity by an order of magnitude (1079.68% activity compared to the wild type enzyme)
E89A
the mutant exhibits 5.46% activity compared to the wild type enzyme
F43A
the mutant exhibits 5.46% activity compared to the wild type enzyme
F87A
the mutant exhibits 3.87% activity compared to the wild type enzyme
W103A
the mutant exhibits 3.05% activity compared to the wild type enzyme
E45A
-
the mutation leads to a drop in the enzyme activity (1.12% activity compared to the wild type enzyme)
-
E45Q
-
the mutation increases the enzyme activity by an order of magnitude (1079.68% activity compared to the wild type enzyme)
-
E89A
-
the mutant exhibits 5.46% activity compared to the wild type enzyme
-
F87A
-
the mutant exhibits 3.87% activity compared to the wild type enzyme
-
W103A
-
the mutant exhibits 3.05% activity compared to the wild type enzyme
-
additional information
D305A
site-directed mutagenesis, in the mutant structure, the hydrogen bonding network between the acidic residues is demolished after incorporating the Ala residue at position 305
the ratio of turnover-number to KM-value for Gln-Gln at pH 8.0 is 200fold lower than wild-type ratio
E201Q
site-directed mutagenesis, the mutant is almost inactive, the side chain of L201 has oriented away from the D305 in the mutant structure
the ratio of turnover-number to KM-value for Gln-Gln at pH 8.0 is 4.9fold lower than wild-type ratio
F325A
the mutant shows a 190fold increase in Ki of PBD150 compared to the wild type enzyme
the ratio of turnover-number to KM-value for Gln-Gln at pH 8.0 is 1.7fold lower than wild-type ratio
K144A
the mutant shows a 1.21fold increase in Ki of PBD150 compared to the wild type enzyme
S160G
site-directed mutagenesis, mutation S160G disrupts the hydrogen bond network at the active site by inducing a swing to the side chain of D248
the ratio of turnover-number to KM-value for Gln-Gln at pH 8.0 is 3.45fold lower than wild-type ratio
W207F
the mutation alters substrate conversion significantly, while the binding constants of inhibitors such as the highly potent PBD150 are minimally affected
W207F
the mutation reduces the turnover rate (kcat) of the enzyme by about 3.7fold compared to the wild type enzyme
the ratio of turnover-number to KM-value for Gln-Gln at pH 8.0 is 56fold lower than wild-type ratio
W207L
the mutation alters substrate conversion significantly, while the binding constants of inhibitors such as the highly potent PBD150 are minimally affected
Y115E/Y117E
site-directed mutagenesis, the double mutation improves the protein solubility compared to wild-type
-
N53A and N123A: no expression of either of the mutants is detected
additional information
knockout of isoQC dramatically reduces the binding of SIRPalpha to cell surface
additional information
generation of QC knock-out mice with no neuronal labeling of the enzyme. Deposition of pE-Abeta only in the brain regions of amyloid precursor protein (APP)-transgenic Tg2576 mice with detectable human APP and endogenous QC expression, such as the hippocampus, piriform cortex, and amygdala. Identification of brain regions with substantial expression of human APP and QC in the absence of pE-Abeta deposition (the Edinger-Westphal nucleus and locus coeruleus). In these brain regions, the enzymes required to generate N-truncated Abeta peptides as substrates for QC might be lacking. In APP-transgenic Tg2576 mice, pE-Abeta deposits concentrate in the neocortex and hippocampus and are not detected in the respective subcortical structures affected by this pathology in Alzheimer's disease brains